Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis

Long-term benefit of using a renin–angiotensin–aldosterone system blocker such as an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) for patients already receiving dialysis remains undetermined. The aim of this study is to assess the efficacy and safety of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Wu, Cho-Kai, Yang, Yao-Hsu, Juang, Jyh-Ming Jimmy, Wang, Yi-Chih, Tsai, Chia-Ti, Lai, Ling-Ping, Hwang, Juey-Jen, Chiang, Fu-Tien, Chen, Pau-Chung, Lin, Jiunn-Lee, Lin, Lian-Yu
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2015
Assuntos:
3400
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602640/
https://ncbi.nlm.nih.gov/pubmed/25621694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados